Ultra SAMe
This product has been discontinued. Label data shown is from the last available version.
Product Information
- Form
- Tablet or Pill
- Servings Per Container
- 60
- Product Type
- Other Combinations
- DSLD Entry Date
- 2012-08-24
Target Groups
Label Statements
General Statements: All Other Content
SAMe is a supplement formed in the body by an enzymatic reaction between adenosine-triphosphate (ATP) and methionine. It was discovered in 1952 in Italy and has been researched and manufactured there. SAMe works closely with folic acid and vitamin B-12 and functions as a methyl donor. This nutrient carries and donates methyl molecules necessary to facilitate the manufacture of DNA and brain neurotransmitters. Tissue levels of SAMe are typically low in the elderly.
Precautions re: All Other
WARNING: Individuals with bipolar (manic) depression should not take SAMe unless under professional medical supervision.
FDA Disclaimer Statement
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
General Statements: All Other Content
Daily Essentials
General Statements: All Other Content
Enteric Coated
Suggested/Recommended/Usage/Directions
Suggested Usage: As a dietary supplement, take 1 tablet 2 to 4 times daily, preferably on an empty stomach. Refrigeration recommended after opening.
Formula re: Contains
200 mg Complex Providing 100 mg SAMe Active Ions
FDA Statement of Identity
Dietary Supplement
Precautions re: All Other
This bottle may contain an insert packet to ensure the freshness of its contents. These packets are not edible and should be discarded.
General Statements: All Other Content
(281) 646-1659
Formula re: Contains
s-adenosyl-methionine
Supplement Facts Panel
* Percent Daily Values are based on a 2,000 calorie diet.
† Daily Value not established.